Strand Therapeutics
Cambridge, MA
Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.
strandtx.comCompany Details
Founded
- 2017
Employees
- Between 50 - 200 employees
Raised
- $104,200,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Jacob Becraft
Founders
- Darrell IrvineRon WeissJacob BecraftTasuku Kitada
Company Collections
These are collections Strand Therapeutics is a part of. Click on the collection name to view similar companies.
Strand Therapeutics' Industries
Strand Therapeutics' Tech Stack
Current Job Listings
Listing 0 of 8 job openings
Strand Therapeutics Headquarters Location
237 Putnam Avenue, Cambridge, MA 02139
Total Amount Raised: $104,200,000
Strand Therapeutics Funding Rounds
Series A
$45,000,000
Series A Investors
FPV VenturesEli Lilly and CompanyPlayground GlobalPotentum PartnersGrant
$400,000
Grant Investors
National Cancer Institute (NCI)Grant
$800,000
Grant Investors
National Cancer Institute (NCI)Series A
$52,000,000
Series A Investors
Playground GlobalCamford CapitalANRIBeiGeneRedmile GroupSeed
$6,000,000
Seed Investors
Playground GlobalAlexandria Real Estate EquitiesANRICreative Destruction Lab (CDL)
Funding info provided by Diffbot.
Strand Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Strand Therapeutics.